Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Heliad Equity Partners KGaA

Start price
Target price
Perf. (%)
€10.55
13.12.21
-
13.12.22
-61.42%
14.12.22

DirectorDealer 
13.12.21 50%
buy
DVS TECHNOLOGY AG

Start price
Target price
Perf. (%)
€17.20
13.12.21
-
13.12.22
-18.60%
14.12.22

DirectorDealer 
13.12.21 50%
buy
Overstock.com

Start price
Target price
Perf. (%)
€65.64
13.12.21
-
13.12.22
-27.86%
09.01.22

Stable Large shareholder and/or long term investor
EBIT decline/stagnation expected
Few uniques
Sustainability is little important
FXX 
13.12.21 40%
buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€14.95
12.12.21
-
12.12.22
1.10%
25.12.21

Could be worthwhile Investment >10% per year
Vassago1 
12.12.21 50%
buy
Radius Health Inc.

Start price
Target price
Perf. (%)
€6.70
12.12.21
-
12.12.22
-5.19%
25.12.21

Could be worthwhile Investment >10% per year
Vassago1 
12.12.21 50%
buy
Myovant Sciences Ltd

Start price
Target price
Perf. (%)
€12.89
12.12.21
-
12.12.22
7.45%
25.12.21

Could be worthwhile Investment >10% per year
Vassago1 
12.12.21 50%
buy
Molecular Templates Inc.

Start price
Target price
Perf. (%)
€3.32
12.12.21
-
12.12.22
2.65%
25.12.21

Could be very worthwhile Investment >20% year
blaugold 
12.12.21 50%
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€45.60
12.12.21
-
12.12.22
23.60%
25.12.21

Could be very worthwhile Investment >20% year
blaugold 
12.12.21 50%
buy
Oncternal Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.61
12.12.21
-
12.12.22
-18.44%
25.12.21

Could be very worthwhile Investment >20% year
blaugold 
12.12.21 50%
buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€3.26
12.12.21
-
12.12.22
9.82%
25.12.21

Could be very worthwhile Investment >20% year
blaugold 
12.12.21 50%
buy
MBB SE

Start price
Target price
Perf. (%)
€133.00
12.12.21
€89.00
12.12.22
-22.11%
13.12.22

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Capable Management
Future proof or reliable business model
geldnutzer 
12.12.21 60%
buy
Valneva SE

Start price
Target price
Perf. (%)
€23.36
12.12.21
-
12.12.22
8.73%
25.12.21

Could be very worthwhile Investment >20% year
quelbe60 
12.12.21 50%
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€151.40
12.12.21
-
12.12.22
5.67%
25.12.21

Could be very worthwhile Investment >20% year
quelbe60 
12.12.21 50%
buy
Clovis Oncology Inc.

Start price
Target price
Perf. (%)
€2.49
12.12.21
-
12.12.22
4.74%
25.12.21

Could be worthwhile Investment >10% per year
thomasw 
12.12.21 50%
buy
Puma Biotechnology Inc.

Start price
Target price
Perf. (%)
€2.48
12.12.21
-
12.12.22
25.48%
25.12.21

Could be worthwhile Investment >10% per year
thomasw 
12.12.21 50%
buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€4.66
12.12.21
-
12.12.22
-1.27%
25.12.21

Could be worthwhile Investment >10% per year
thomasw 
12.12.21 50%
buy
Sio Gene Therapies Inc.

Start price
Target price
Perf. (%)
€1.22
12.12.21
-
12.12.22
1.64%
25.12.21

Could be worthwhile Investment >10% per year
thomasw 
12.12.21 50%
buy
Nel ASA

Start price
Target price
Perf. (%)
€1.63
12.12.21
-
12.12.22
-6.36%
22.12.21

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Mori8 
12.12.21 50%
buy
Gesco AG NA

Start price
Target price
Perf. (%)
€25.00
11.12.21
€33.00
11.12.22
-3.60%
12.12.22

Revenue growth > 30% per year expected
Top 10 in its market
Could be worthwhile Investment >10% per year
Innovative
kostojunior 
11.12.21 70%
buy
Orbis AG

Start price
Target price
Perf. (%)
€7.80
11.12.21
€9.00
11.12.22
-11.54%
12.12.22

Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
kostojunior 
11.12.21 77%
buy
Valneva SE

Start price
Target price
Perf. (%)
€23.36
11.12.21
€30.00
11.12.22
8.73%
25.12.21

Fair valuation
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Higher risks for its business
skatcup 
11.12.21 100%
sell
Epizyme Inc.

Start price
Target price
Perf. (%)
€2.63
11.12.21
-
11.12.22
-45.63%
08.12.22

Probably not worthwhile Investment
Lokrim 
11.12.21 20%
sell
Karyopharm Therapeutics Inc.

Start price
Target price
Perf. (%)
€5.24
11.12.21
-
11.12.22
-16.73%
08.12.22

Risky Investment
Lokrim 
11.12.21 20%
buy
CropEnergies AG

Start price
Target price
Perf. (%)
€12.24
11.12.21
-
11.12.22
10.46%
12.12.22

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Growths much faster than the competition
Very Future proof/growth oriented business model
Maxi_Scalibusa 
11.12.21 0%
buy
MBB SE

Start price
Target price
Perf. (%)
€128.60
10.12.21
-
10.12.22
-15.71%
11.12.22

DirectorDealer 
10.12.21 50%